# Trip.com Group Ltd: Form 20-F for the period ended Dec 31, 2025

- Company: [Trip.com Group Ltd](/companies/tcom.md) (CIK 1269238)
- Form: 20-F
- Filed: 2026-04-28
- Accepted by EDGAR: Apr 28, 2026, 06:09 ET
- Period: 2025-12-31
- Accession: 0001193125-26-183379
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1269238/000119312526183379/d27369d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1269238/000119312526183379/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $8.93bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $1.73bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $7.19bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $2.16bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $2.26bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $121.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $832.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $4.76bn | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 698,378,891 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $2.06bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $114.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2025-01-01 to 2025-12-31 | $204.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months, 2025-01-01 to 2025-12-31 | $629.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-12-31 | $5.70bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $17.31bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $38.24bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $11.18bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $13.55bn | us-gaap:Liabilities |
| Long-term debt | at 2025-12-31 | $1.63bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-12-31 | $2.77bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2025-12-31 | $24.43bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-12-31 | 649,583,574 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1269238/000119312526183379/d27369d20f.htm

Filed Apr 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-183379. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.